STAMFORD, Conn., March 30, 2011 /PRNewswire/ -- Attendees of the 60th annual American College of Cardiology (ACC) Scientific Session in New Orleans, La., can see first hand the benefits of Synapse® 3D from FUJIFILM Medical Systems U.S.A., Inc. Available for sale in the U.S., Synapse 3D is a comprehensive suite of clinical applications that is integrated directly into Synapse® Cardiovascular, Fujifilm's CVIS / C-PACS. During the ACC conference Fujifilm will demonstrate the product's diagnostic benefits and explain how it can enhance workflow and reporting while also providing cost savings.
Developed by Fujifilm and utilizing the company's core competency in image processing, Synapse 3D can enhance clinical capabilities with its broad range of applications such as CT coronary angiography, CT and MR cardiac function analysis, calcium scoring, and cardiac fusion, allowing fusion of PET, MR, CT, SPECT, CT Function or MR Function. Other standard tools included are 2D, 3D (includes stenosis and plaque measurements), and 4D viewer, Sector MPR (multi-planar reconstruction), and Dynamic Data. Using Fujifilm's patented algorithms, Synapse 3D delivers image visualization benefits such as precise segmentation and analysis. Additionally, the application is powered by an enterprise, scalable server-based rendering technology that enables the cardiologist to perform the analysis quickly.
"By combining Fujifilm's core strength in image processing with our ability to integrate our 3D product with our CVIS/C-PACS, we are able to deliver a solution with unrivaled benefits," said Jim Morgan, Fujifilm's Vice President, Medical Informatics. "During trials and research Synapse 3D has proven to be a powerful and efficient diagnostic tool, and we're confident that we will be seeing widespread adoption by cardiologists."